多祖先转录组-广泛关联认知功能,白质过强度和阿尔茨海默病的研究
Dima L Chaar1, Zheng Li2, Lulu Shang3
1Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, MI 48109, USA.
International journal of molecular sciences
|March 27, 2025
概括
这项研究开创了针对神经认知障碍的多祖先转录全基因组关联研究 (TWAS). 它确定了与认知功能,白质过强度和阿尔茨海默病相关的新型基因,在不同人群中推进了痴呆症研究.
科学领域:
- 神经遗传学 神经遗传学
- 基因组学就是基因组学.
- 神经科学是一个神经科学.
背景情况:
- 遗传变异影响神经认知障碍,如阿尔茨海默病 (AD) 和血管痴呆症 (VaD).
- 现有的全转录组关联研究 (TWAS) 主要使用单个祖先数据,限制了概括性.
- 了解痴呆症的遗传因素需要多样化的人口数据.
研究的目的:
- 进行第一个多祖先的TWAS用于认知功能和神经认知障碍.
- 识别与一般认知功能,白质过强度 (WMH) 和AD相关的基因和生物途径.
- 探索欧洲和非洲祖先对痴呆症的遗传影响.
主要方法:
- 利用多祖先转录Ome-wide分析 (METRO) 框架与来自欧洲 (EA) 和非洲 (AA) 祖先样本的基因表达数据.
- 对认知功能,WMH和AD进行了全转录组协会研究 (TWASs).
- 使用因果基因组细映射 (FOCUS) 精细映射候选因果基因.
主要成果:
- 确定了266个用于一般认知功能的基因,23个用于WMH,69个用于AD (EA GWAS) 和2个用于AD (AA GWAS).
- 丰富分析揭示了参与天生的免疫力,血管功能障碍和神经炎症的途径.
- 降低ICA1L的调节与增加WMH和AD风险相关,这表明在重叠的神经病理学中发挥了作用.
结论:
- 这种多祖先的TWAS扩大了对认知功能和神经认知障碍的遗传发现的范围.
- 研究结果强调了多样化人口在痴呆症遗传研究中的重要性.
- 已识别的基因和途径为痴呆症和相关疾病提供了潜在的治疗点.
更多相关视频
09:38Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
Published on: November 14, 2017
14.8K
04:22Author Spotlight: Exploring Sex-Specific Glial Signatures and Therapeutic Leads for Alzheimer's Disease
Published on: May 20, 2024
742
相关概念视频
Genome-wide Association Studies-GWAS
12.3K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
12.3K
Alzheimer's Disease: Overview
409
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
409
